The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Targeting the C5 subclass of high-grade serous ovarian cancer using patient-derived xenografts: Microtubule polymerisation inhibitors.
 
Valerie Heong
Honoraria - Pfizer
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Janssen-Cilag
 
Monique Topp
No Relationships to Disclose
 
Sumitra Ananda
No Relationships to Disclose
 
Orla McNally
No Relationships to Disclose
 
Geoffrey John Lindeman
No Relationships to Disclose
 
Paul Haluska
Honoraria - Boehringer Ingelheim
Consulting or Advisory Role - Boehringer Ingelheim
Research Funding - Clovis Oncology (Inst); Genentech (Inst); MedImmune (Inst); Merck (Inst); Nektar (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - MayoAvatar Programme
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Matthew Wakefield
No Relationships to Disclose
 
Elizabeth M. Swisher
Travel, Accommodations, Expenses - Clovis Oncology
 
David SP Tan
Honoraria - Roche Pharma AG
Research Funding - Karyopharm Therapeutics (Inst)
 
Huang Ruby
No Relationships to Disclose
 
David Bowtell
Honoraria - AstraZeneca
 
Clare L. Scott
Honoraria - Roche
Consulting or Advisory Role - AstraZeneca; Clovis Oncology
Speakers' Bureau - Prime Oncology
Expert Testimony - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; Roche
Other Relationship - Clovis Oncology